Cargando…
Neuromodulation in Drug Resistant Epilepsy
Epilepsy affects approximately 70 million people worldwide, and it is a significant contributor to the global burden of neurological disorders. Despite the advent of new AEDs, drug resistant-epilepsy continues to affect 30-40% of PWE. Once identified as having drug-resistant epilepsy, these patients...
Autores principales: | Rincon, Natalia, Barr, Donald, Velez-Ruiz, Naymee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219496/ https://www.ncbi.nlm.nih.gov/pubmed/34221550 http://dx.doi.org/10.14336/AD.2021.0211 |
Ejemplares similares
-
Cutting the Losses of Pregnant Women With Epilepsy
por: Velez-Ruiz, Naymee
Publicado: (2019) -
Emerging Trends in Neuromodulation for Treatment of Drug-Resistant Epilepsy
por: Abouelleil, Mohamed, et al.
Publicado: (2022) -
Drug‐resistant epilepsy and mortality—Why and when do neuromodulation and epilepsy surgery reduce overall mortality
por: Rheims, Sylvain, et al.
Publicado: (2022) -
Stimulation and Neuromodulation in the Treatment of Epilepsy
por: Eastin, Timothy Marc, et al.
Publicado: (2017) -
Is Spontaneity Overrated? The Value of Cortical Stimulation–Induced
Seizures
por: Velez-Ruiz, Naymee
Publicado: (2019)